How Russian drug regulation compares with ICH countries
This article was originally published in SRA
Executive Summary
Andrei Meshkovski and Alan Chalmers report on the sometimes striking differences between the regulatory framework for pharmaceuticals in Russia and the systems in place in markets such as the EU, Japan and the US.